Enanta CEO Jay Luly Plans to Retire Early Next Year
Enanta Pharmaceuticals said Jay Luly, 70, plans to retire as president and chief executive early next year after more than two decades leading the clinical-stage biotechnology company.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.